Public disclosures

Zhang Ingrid

Company insiders · Chief Executive Officer · Legend Biotech Corp

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
3
Buy lines
1
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-113

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Zhang Ingrid

Chief Executive Officer · Legend Biotech Corp

LEGN

Legend Biotech Corp

Buy
Filing details

SEC transaction code P

Ordinary Shares · Direct ownership · Reported balance after transaction: 1151860 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $16.32 per ADS.

2026-11-172026-11-20

≈ $163,200.00

20,000 shares/units

SEC 4
Zhang Ingrid

Director · METTLER TOLEDO INTERNATIONAL INC/

MTD

METTLER TOLEDO INTERNATIONAL INC/

Equity grant or award
Filing details

SEC transaction code A

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 130 · The options vest annually in two equal installments beginning on the first anniversary of the date of grant.

2026-11-102026-11-12

130 shares/units

SEC 4
Zhang Ingrid

Director · METTLER TOLEDO INTERNATIONAL INC/

MTD

METTLER TOLEDO INTERNATIONAL INC/

Equity grant or award
Filing details

SEC transaction code A

Common Stock, par value $0.01 per share · Direct ownership · Reported balance after transaction: 261

2026-11-102026-11-12

54 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement